# Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life

> **NCT04356209** · PHASE2 · RECRUITING · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 105 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** e-PRO Intervention
- **DRUG:** Pravastatin

## Key facts

- **NCT ID:** NCT04356209
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-31
- **Primary completion:** 2026-01-31
- **Final completion:** 2031-01-31
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04356209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04356209, "Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04356209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*